No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly females |
313377 |
2. Check conditionsNone |
313377 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
544 |
4. Check minimum number of eventsNone |
544 |
5. Include endpointsNone |
544 |
6. Filter based on genotype QC (FinnGen only) |
496 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of vulva, including Hilmo
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of female genital organs, including Hilmo
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
- Malignant neoplasm, including Hilmo
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 496 | 496 | - |
| Unadjusted period prevalence (%) | 0.18 | 0.18 | - |
| Median age at first event (years) | 67.10 | 67.10 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 512
- Matched controls
- 5120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
63.8
307.7
267
86
ULA02
NOMESCO Finland
Kolposcopy
21.2
281.0
293
304
LFC00
NOMESCO Finland
Partial excision of vulva
1562.7
215.9
195
*
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
96.4
215.3
113
15
H02AB02
ATC
dexamethasone; systemic
60.4
205.3
117
25
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
+∞
168.3
152
*
PJA12
NOMESCO Finland
Sentinel node biopsy
2014.5
157.9
145
*
8070/3-C51.9
ICD-O-3
Squamous cell carcinoma, NOS, of vulva, NOS
+∞
143.7
131
*
B01AB10
ATC
tinzaparin; parenteral
11.0
142.7
192
264
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
+∞
127.6
117
*
C51.9
ICD-10 Finland
Malignant neoplasm: Vulva, unspecified
+∞
115.0
106
*
LEB00
NOMESCO Finland
Biopsy of vagina
23.5
106.7
80
40
128
Kela drug reimbursment
Cancers of female genital organs
+∞
103.8
96
*
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
+∞
100.4
93
*
XX3DW
NOMESCO Finland
Time consuming IT work
11.7
100.2
115
124
JN4AD
NOMESCO Finland
Body CT examination
10.6
99.4
124
150
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
7.0
93.2
189
396
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
19.6
90.2
73
43
L02BG04
ATC
letrozole; oral
56.5
89.4
51
10
N76.6
ICD-10 Finland
Ulceration of vulva
35.5
89.0
57
18
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
9.5
86.9
117
155
A03FA01
ATC
metoclopramide; systemic, rectal
5.9
80.6
199
495
LFD10
NOMESCO Finland
Vulvectomy and excision of regional lymph nodes
+∞
80.4
75
*
JN4BD
NOMESCO Finland
Extensive body CT
11.0
76.8
89
96
115
Kela drug reimbursment
Breast cancer
+∞
71.6
67
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
31.5
69.4
46
16
WZC00
NOMESCO Finland
Treatment plan or consultation
4.8
69.3
274
985
WF003
NOMESCO Finland
Adjuvant radiotherapy
740.2
67.6
65
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
67.2
63
*
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
11.3
62.7
70
71
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
5.8
62.7
142
320
A04AA01
ATC
ondansetron; systemic, rectal
9.7
62.5
79
95
C51.00
ICD-10 Finland
Malignant tumor of the labium majus without histology
+∞
61.7
58
*
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
341.1
60.7
60
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
60.6
57
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
106.1
60.5
65
7
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
121.6
60.4
64
6
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
10.7
60.3
70
75
ZZR00
NOMESCO Finland
Flap of skin
104.3
59.4
64
7
WF002
NOMESCO Finland
Radical radiotherapy
166.3
57.2
59
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
56.3
53
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
54.1
51
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
11.5
50.8
55
53
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.1
48.2
120
289
Z51.5
ICD-10 Finland
Palliative care
7.1
47.7
78
126
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
47.7
45
*
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
16.6
46.5
40
26
HA1AA
NOMESCO Finland
X-ray mammography
7.0
46.1
77
127
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
252.1
45.8
46
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
465.3
43.9
43
*
HAC20
NOMESCO Finland
Total mastectomy
240.1
43.6
44
*
C51.04
ICD-10 Finland
Basal cell carcinoma of labium majus
+∞
43.3
41
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
43.3
41
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
13.0
42.4
42
35
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.4
40.5
257
1175
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
40.1
38
*
130
Kela drug reimbursment
Malignant tumour
+∞
40.1
38
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
39.1
37
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
406.3
38.6
38
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
38.0
36
*
D07AD01
ATC
clobetasol; topical
3.5
37.7
177
667
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
36.9
35
*
L03AA13
ATC
pegfilgrastim; parenteral
383.0
36.5
36
*
C51.1
ICD-10 Finland
Malignant neoplasm: Labium minus
+∞
35.9
34
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.0
35.3
57
90
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
34.8
33
*
C51.21
ICD-10 Finland
Squamous cell carcinoma of the clitoris
+∞
34.8
33
*
D39.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other female genital organs
99.5
34.2
37
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.7
33.8
68
134
WZC30
NOMESCO Finland
Teaching
3.9
33.2
117
361
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
344.1
32.2
32
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
121.1
32.1
34
*
8070/3-C51.1
ICD-O-3
Squamous cell carcinoma, NOS, of labium minus
+∞
31.6
30
*
LFD00
NOMESCO Finland
Vulvectomy
+∞
31.6
30
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
332.2
31.2
31
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
30.5
29
*
C51.0
ICD-10 Finland
Malignant neoplasm: Labium majus
+∞
29.5
28
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.2
28.6
63
134
A04AD12
ATC
aprepitant; systemic
+∞
28.4
27
*
WF004
NOMESCO Finland
Palliative radiotherapy
296.9
28.0
28
*
B01AB05
ATC
enoxaparin; parenteral
2.8
27.8
234
1191
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.4
27.6
37
47
8070/3-C51.0
ICD-O-3
Squamous cell carcinoma, NOS, of labium majus
+∞
27.3
26
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
27.3
26
*
C51.09
ICD-10 Finland
Malignant tumor of the labium majus, unspecified histology
+∞
27.3
26
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
27.3
26
*
N02AA05
ATC
oxycodone; systemic
3.1
27.2
150
607
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.0
27.1
38
51
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.0
26.9
34
40
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
26.3
25
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
98.6
25.9
28
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
142.2
25.9
27
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
25.2
24
*
C51.89
ICD-10 Finland
Overall malignant tumor of the vulva, unspecified histology
+∞
25.2
24
*
C51.19
ICD-10 Finland
Adenocarcinoma of the labium minus, unspecified histology
+∞
25.2
24
*
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
24.2
24.2
34
15
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
24.2
23
*
L02BA01
ATC
tamoxifen; oral
251.3
23.8
24
*
WX402
NOMESCO Finland
General anaesthesia
3.0
23.5
132
536
X77
ICPC
Malignant neopl genital female other
+∞
23.1
22
*
8090/3-C51.9
ICD-O-3
Basal cell carcinoma, NOS, of vulva, NOS
+∞
23.1
22
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
23.1
22
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.1
21.2
47
100
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
21.0
69
200
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
21.0
20
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
114.7
20.7
22
*
A46
ICD-10 Finland
Erysipelas
2.9
20.4
113
452
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
4.0
20.0
62
172
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
19.9
19
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
19.9
19
*
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
25.8
19.7
27
11
HAB40
NOMESCO Finland
Wedge excision of mammary gland
27.3
19.3
26
10
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
18.9
18
*
8542/3-C51.9
ICD-O-3
Paget disease, extramammary of vulva, NOS
+∞
18.9
18
*
WW500
NOMESCO Finland
Blood transfusion
7.3
18.8
28
40
ZX120
NOMESCO Finland
Intravenous
3.9
18.5
58
162
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
45.8
18.4
22
5
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
27.9
18.0
24
9
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
69.2
17.8
20
*
8720/3-C51.9
ICD-O-3
Malignant melanoma, NOS, of vulva, NOS
+∞
17.8
17
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
17.8
17
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
186.2
17.6
18
*
N90.0
ICD-10 Finland
Mild vulvar dysplasia
32.7
17.2
22
7
L01BC06
ATC
capecitabine; oral
+∞
16.8
16
*
8090/3-C51.0
ICD-O-3
Basal cell carcinoma, NOS, of labium majus
+∞
16.8
16
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.2
16.6
35
71
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
175.5
16.6
17
*
LFE10
NOMESCO Finland
Plastic repair of vulva
49.2
16.1
19
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
15.7
75
274
C51.13
ICD-10 Finland
Melanoma and labium minus
+∞
15.7
15
*
A79
ICPC
Malignancy NOS
+∞
15.7
15
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
15.7
15
*
C51.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of vulva
+∞
15.7
15
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
15.7
15
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
15.7
15
*
Z51.0
ICD-10 Finland
Radiotherapy session
164.8
15.6
16
*
C50
ICD-10 Finland
Malignant neoplasm of breast
164.8
15.6
16
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
164.8
15.6
16
*
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
39.4
15.5
19
5
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.9
15.4
35
76
D06BB10
ATC
imiquimod; topical
3.8
15.3
49
139
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
15.2
140
708
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
46.5
15.2
18
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
46.5
15.2
18
*
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
15.7
15.0
24
16
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.6
15.0
102
449
C519, 8086, 3
ICD-O-3
+∞
14.7
14
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
14.7
14
*
L02BG03
ATC
anastrozole; oral
+∞
14.7
14
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
82.5
14.6
16
*
WZC15, ,
NOMESCO Finland
77.2
13.6
15
*
TQW99
NOMESCO Finland
Other minor procedure on skin
3.9
13.6
41
111
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
13.6
13
*
L03AA02
ATC
filgrastim; parenteral
+∞
13.6
13
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
13.6
13
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
13.0
70
272
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
12.9
112
548
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.7
12.8
30
67
J01CE08
ATC
benzathine benzylpenicillin; parenteral
12.7
12.7
22
18
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
71.7
12.6
14
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
12.5
12
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
12.5
12
*
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
+∞
12.5
12
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
12.5
12
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
12.5
12
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
133.1
12.5
13
*
WX320
NOMESCO Finland
Spinalanesthesy
2.1
12.4
171
1004
P01AB01
ATC
metronidazole; oral, rectal
1.9
12.2
259
1765
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
47.8
11.9
14
*
TJF80
NOMESCO Finland
Ostomy education
47.8
11.9
14
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
66.5
11.7
13
*
XX2RW, ,
NOMESCO Finland
23.5
11.6
16
7
C52.91
ICD-10 Finland
Squamous cell carcinoma of the vagina
+∞
11.5
11
*
C519, 8085, 3
ICD-O-3
+∞
11.5
11
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
122.7
11.5
12
*
5702
FHL
Local lymph node removal (eg armpit, groin)
122.7
11.5
12
*
LFE96
NOMESCO Finland
Other repair of vulva or perineum
122.7
11.5
12
*
J01DB01
ATC
cefalexin; oral
2.4
11.4
436
3616
LCA06
NOMESCO Finland
Biopsy of endometrium
2.3
11.4
101
498
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
25.7
11.2
15
6
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.2
11.1
30
75
D70.82
ICD-10 Finland
Drug-induced neutropenia
44.3
11.0
13
*
D28.0
ICD-10 Finland
Benign neoplasm: Vulva
12.3
10.9
19
16
X16
ICPC
Vulval symptom/complaint
5.3
10.9
22
43
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
10.8
122
662
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
10.7
198
1275
LFW96
NOMESCO Finland
Other operation on vulva or perineum
61.3
10.7
12
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
112.2
10.5
11
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
112.2
10.5
11
*
C51.84
ICD-10 Finland
Overall basal cell carcinoma of vulva
+∞
10.4
10
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
10.4
10
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
10.4
10
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
10.4
10
*
C511, 8086, 3
ICD-O-3
+∞
10.4
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.4
10
*
TQW20
NOMESCO Finland
Tatoe
+∞
10.4
10
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
10.4
10
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
10.4
10
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
10.4
10
*
C51.03
ICD-10 Finland
Melanoma and labium majus
+∞
10.4
10
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
10.4
10
*
Z93.3
ICD-10 Finland
Colostomy status
33.3
10.4
13
*
N90.4
ICD-10 Finland
Leukoplakia of vulva
10.9
10.4
19
18
JFF23
NOMESCO Finland
Transversostomy
23.9
10.3
14
6
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
10.2
77
352
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
17.1
9.9
15
9
D05BB02
ATC
acitretin; oral
4.8
9.9
22
47
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.3
9.8
38
122
X81
ICPC
Genital neopl female other/unspecif
56.1
9.7
11
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
7.4
9.6
22
31
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
9.4
9
*
C510, 8086, 3
ICD-O-3
+∞
9.4
9
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
9.4
9
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
9.4
9
*
L02BG06
ATC
exemestane; oral
+∞
9.4
9
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
9.4
9
*
A63.0
ICD-10 Finland
Anogenital (venereal) warts
4.6
9.2
22
50
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
37.4
9.0
11
*
TQW40
NOMESCO Finland
Remowal of suture of skin
2.7
9.0
49
191
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
2.8
8.8
44
164
X76
ICPC
Malignant neoplasm breast female
50.9
8.7
10
*
E0000UV, ,
ATC
1.7
8.6
240
1720
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
8.6
260
1906
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.3
8.5
70
332
JN4CD
NOMESCO Finland
Very extensive body CT
8.8
8.4
17
20
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
8.4
8
*
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
+∞
8.4
8
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
8.4
8
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
8.4
8
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
8.4
8
*
C51.14
ICD-10 Finland
Basal cell carcinoma of labium minus
+∞
8.4
8
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
11.0
8.3
15
14
ZXC40
NOMESCO Finland
Use of ultrasound
17.5
8.1
12
7
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
33.9
8.1
10
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
33.9
8.1
10
*
L04AA06
ATC
mycophenolic acid; systemic
7.4
8.0
18
25
R50.9
ICD-10 Finland
Fever, unspecified
2.2
8.0
74
369
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
15.3
7.7
12
8
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
7.6
7.7
17
23
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
7.7
68
332
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.3
7.5
17
24
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.6
7.5
44
179
QB4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in groin or genital area (from front)
81.2
7.4
8
*
KDD00
NOMESCO Finland
Partial excision of urethra
81.2
7.4
8
*
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
11.1
7.3
13
12
1844A
ICD-9 Finland
Malignant neoplasm of other and unspecified female genital organs, Vulva, unspecified
+∞
7.3
7
*
8070/3-C52.9
ICD-O-3
Squamous cell carcinoma, NOS, of vagina, NOS
+∞
7.3
7
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
18411
ICD-8 Finland
Malignant neoplasm of other and unspecified female genital organs, Vulva
+∞
7.3
7
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
7.3
7
*
8477
FHL
Vulvectomy
+∞
7.3
7
*
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
16.0
7.3
11
7
HAB99
NOMESCO Finland
Other partial excision of mammary gland
8.1
7.1
15
19
L57.0
ICD-10 Finland
Actinic keratosis
2.2
7.1
64
315
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
12.3
7.1
12
10
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
7.1
73
379
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
10.2
7.1
13
13
Z3231
NOMESCO Finland
Registered nurse
1.8
7.0
138
886
E000006, ,
ATC
2.3
7.0
53
243
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
7.0
30
103
TQW80
NOMESCO Finland
Local dermatologic skincare
3.9
6.9
20
53
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.2
6.8
17
28
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.3
6.8
54
252
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
6.7
107
646
S18
ICPC
Laceration/cut
1.6
6.6
246
1864
J01MA12
ATC
levofloxacin; systemic
1.9
6.5
93
540
HA1SA
NOMESCO Finland
Expansion mammography
70.7
6.4
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
70.7
6.4
7
*
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
70.7
6.4
7
*
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
14.5
6.4
10
7
J01FF01
ATC
clindamycin; systemic
1.7
6.3
139
918
1841A
ICD-9 Finland
Malignant neoplasm of other and unspecified female genital organs, Labia majora
+∞
6.3
6
*
C51.83
ICD-10 Finland
Overall melanoma of the vulva
+∞
6.3
6
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
C510, 8085, 3
ICD-O-3
+∞
6.3
6
*
C21.0
ICD-10 Finland
Malignant neoplasm: Anus, unspecified
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.3
6
*
8070/2-C51.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of vulva, NOS
+∞
6.3
6
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
6.3
6
*
XQ848
NOMESCO Finland
Dermatological photography
3.8
6.3
19
52
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
6.2
129
838
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.7
6.1
33
129
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.3
6.1
22
68
SPAT1254
SPAT
Administration of medicine
1.8
6.0
92
546
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
359
1950
3.81
43.83
4.0
2.3
—
—
estimate
—
0
0
183
670
3.69
41.22
3.8
2.1
0.76
0.82
mmol/l
9.21
173
597
115
346
4.00
33.90
2.6
1.9
0.22
0.20
g/l
2.24
107
324
205
1011
2.71
25.45
3.2
1.9
—
—
—
0
0
334
2101
2.70
25.03
6.2
3.5
34.59
35.63
g/l
2.74
318
1945
343
2290
2.51
21.02
8.3
3.4
9.42
10.52
umol/l
2.74
327
2141
353
2433
2.45
19.44
13.6
6.5
4.16
4.18
e9/l
0.05
316
2084
62
190
3.57
17.30
1.7
1.5
—
—
—
0
0
167
886
2.31
16.40
1.7
1.4
—
—
—
0
0
184
1018
2.26
16.34
5.3
3.3
93.94
91.44
%
0.59
179
998
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
40
105
4.05
13.87
2.6
2.6
0.43
0.43
iu/ml
0.01
21
67
69
259
2.92
13.72
4.1
1.4
12.67
2.64
ug/l
0.65
52
198
305
2162
2.02
13.18
13.4
16.0
1.17
1.28
inr
3.13
261
1791
336
2491
2.01
12.47
8.1
5.5
1.22
1.22
mmol/l
1.14
289
2165
306
2212
1.95
12.03
7.9
4.9
1.22
1.22
mmol/l
0.54
285
2002
119
634
2.14
11.03
2.2
1.7
28.72
29.07
s
0.31
114
613
421
3482
2.18
10.39
11.7
5.6
81.85
77.04
u/l
1.34
401
3236
25
58
4.48
10.16
1.2
1.3
—
—
—
0
0
106
563
2.11
9.81
4.6
3.4
1.03
1.04
mmol/l
0.16
95
497
92
466
2.19
9.60
4.3
3.3
—
—
—
0
0
346
2707
1.86
9.59
6.2
4.2
6.90
6.69
mmol/l
1.02
327
2560
219
1501
1.80
9.40
3.9
3.3
25.22
45.68
e6/l
1.15
176
1165
390
3199
1.92
8.96
7.0
5.7
24.88
5218.98
e6/l
—
8
41
189
1282
1.75
8.13
3.9
3.2
0.40
0.47
e6/l
0.30
145
965
329
2621
1.71
7.66
5.5
4.6
0.00
0.01
estimate
0.97
77
508
237
1732
1.69
7.64
4.8
4.0
139.84
116.06
e6/l
0.25
180
1209
128
794
1.82
7.35
2.1
1.9
—
—
—
0
0
40
159
2.64
7.12
1.9
1.5
1.23
1.31
ug/l
0.05
30
140
90
504
1.95
7.07
8.0
5.2
0.76
1.51
mmol/l
0.91
77
425
238
1769
1.65
7.00
4.7
2.1
2.37
2.37
mmol/l
0.17
219
1555
30
105
2.97
6.75
1.5
1.6
—
—
—
0
0
47
213
2.33
6.36
4.0
3.2
1.63
2.26
mmol/l
0.48
35
156
201
1459
1.62
6.34
5.6
4.5
0.00
0.00
estimate
-0.00
70
474
12
13
9.42
6.31
4.2
1.3
13.09
15.10
ug/l
0.50
12
13
82
463
1.92
6.26
4.3
2.6
1.57
2.36
mmol/l
0.92
72
408
107
661
1.78
6.14
3.0
2.3
19.86
20.64
%
0.23
90
608
16
39
4.20
6.13
1.3
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
6
15.23
5.92
1.3
1.3
154.00
157.83
%
—
9
6
11
12
9.34
5.81
1.9
1.4
15.09
17.17
%
0.18
11
12
154
1065
1.64
5.81
3.4
2.6
5.93
8.01
e6/l
1.23
144
980
52
257
2.14
5.72
4.1
3.3
4.90
5.26
kpa
2.44
47
243
68
374
1.94
5.60
5.3
2.7
1.23
1.23
mmol/l
0.46
58
304
76
434
1.88
5.60
2.5
2.5
3.19
5.52
ug/l
1.93
61
373
11
13
8.62
5.58
2.1
1.6
—
—
—
0
0
113
728
1.71
5.56
2.8
2.3
2.23
2.38
g/l
1.78
97
665
8
5
16.23
5.42
2.0
7.4
1.50
0.40
%
—
8
5
121
800
1.67
5.39
3.3
2.9
2.43
2.06
e6/l
0.14
73
433
12
18
6.80
5.28
2.2
1.6
—
—
—
0
0
63
347
1.93
5.17
1.9
1.6
—
—
—
0
0
96
603
1.73
5.15
1.9
1.9
—
—
—
0
0
99
628
1.71
5.13
8.3
7.0
—
—
—
0
0
26
99
2.71
5.06
1.3
1.7
—
—
—
0
0
146
1028
1.59
5.01
1.8
1.6
1.02
1.18
mg/l
0.55
113
809
115
787
1.59
4.40
2.9
2.3
11.13
12.22
umol/l
0.79
98
724
63
366
1.82
4.40
2.4
2.3
66.04
66.31
ml/min/173m2
0.02
24
149
88
569
1.66
4.22
1.9
1.9
—
—
—
0
0
75
465
1.72
4.20
3.2
1.8
376.08
375.27
nmol/l
0.01
65
420
73
455
1.70
4.01
3.1
2.0
6.06
5.67
umol/l
0.14
60
387
9
14
6.52
4.00
1.1
1.3
—
—
—
0
0
307
2606
1.44
3.96
5.7
4.5
38.25
0.00
estimate
0.79
85
522
304
2577
1.44
3.94
5.7
4.5
0.00
0.00
estimate
-0.00
79
500
161
2044
0.69
3.67
1.9
1.9
1.37
1.30
mmol/l
0.51
131
1718
42
228
1.92
3.63
1.4
1.5
—
—
—
0
0
65
404
1.70
3.61
2.8
1.5
64.54
67.15
g/l
1.71
56
365
51
296
1.80
3.59
2.6
3.2
4.69
4.42
pmol/l
0.52
45
257
24
109
2.26
3.30
1.4
1.4
—
—
—
0
0
16
60
2.72
3.25
1.1
1.3
—
—
—
0
0
21
91
2.36
3.21
3.0
2.5
15.24
16.12
%
0.74
21
91
187
1498
1.39
3.13
3.7
2.3
56.27
60.16
u/l
0.33
171
1355
99
706
1.50
3.10
3.4
3.0
3.98
4.64
e6/l
0.18
47
332
42
241
1.81
3.09
4.2
2.5
25.49
25.78
mmol/l
0.26
42
233
16
63
2.59
2.98
1.3
1.4
—
—
—
0
0
28
142
2.03
2.96
1.3
1.5
0.45
0.10
iu/ml
—
9
25
52
322
1.68
2.95
3.7
2.4
124.37
127.26
g/l
0.42
52
311
12
40
3.05
2.71
2.0
1.8
—
267.20
—
0
5
24
119
2.07
2.70
2.3
2.9
—
—
—
0
0
426
4503
0.68
2.61
6.0
6.5
2.67
2.69
mmol/l
0.20
379
4137
465
4404
1.61
2.51
28.3
14.9
27.14
21.29
mg/l
3.82
420
3568
9
26
3.50
2.49
1.0
1.7
—
—
—
0
0
12
45
2.71
2.46
1.0
1.0
—
—
—
0
0
68
471
1.51
2.45
3.7
2.9
99.65
79.56
ng/l
0.73
48
407
5
8
6.30
2.37
3.0
3.3
0.56
0.60
mmol/l
—
5
8
12
46
2.65
2.37
1.8
1.3
41.90
37.08
u/l
0.19
12
32
453
4276
1.52
2.36
25.8
14.4
74.20
74.30
ml/min/173m2
0.04
426
3960
24
126
1.95
2.35
4.4
1.5
1.23
1.32
ratio
0.26
16
77
408
4328
0.72
2.28
7.6
7.0
40.03
39.79
mmol/mol
0.19
373
4023
415
4389
0.71
2.26
5.2
5.5
1.54
1.59
mmol/l
1.33
368
4015
19
93
2.08
2.24
1.3
1.3
—
—
—
0
0
10
36
2.81
2.15
1.2
1.1
—
—
—
0
0
12
49
2.48
2.12
1.2
1.3
—
—
—
0
0
158
1299
1.31
2.10
2.8
2.4
3.06
2.93
mg/l
0.31
125
1108
224
1939
1.28
1.98
5.1
4.1
65.24
106.31
ng/l
0.33
180
1432
22
120
1.87
1.96
4.3
3.4
0.93
0.82
index
0.07
15
45
421
4424
0.73
1.95
5.4
5.5
4.68
4.73
mmol/l
0.43
382
4065
197
1685
1.27
1.90
3.5
3.2
1558.06
1208.86
ng/l
0.68
162
1447
304
2745
1.26
1.84
3.7
3.0
62.28
43.95
u/l
1.86
286
2528
7
23
3.07
1.80
1.0
1.2
853.00
156.27
u/l
—
7
23
166
1398
1.28
1.80
4.8
2.5
32.83
29.59
u/l
0.77
159
1312
20
109
1.87
1.80
3.4
1.7
34.56
13.73
u/ml
0.84
15
91
11
47
2.37
1.79
1.0
1.1
4.50
3.33
u/ml
—
6
18
18
96
1.91
1.73
1.4
1.3
—
—
—
0
0
135
1117
1.28
1.67
3.9
2.3
2.50
2.47
mmol/l
2.54
125
1001
14
69
2.06
1.66
1.2
1.2
—
—
—
0
0
10
41
2.47
1.65
1.2
1.1
—
—
—
0
0
222
1955
1.24
1.61
6.1
4.4
0.00
0.04
estimate
1.80
60
404
6
20
3.02
1.58
4.3
5.4
—
—
—
0
0
5
15
3.36
1.52
1.2
1.3
3.88
4.33
mg/l
—
5
15
5
15
3.36
1.52
6.6
2.9
0.60
1.13
index
—
5
15
43
304
1.45
1.46
1.7
1.8
—
—
—
0
0
13
66
1.99
1.44
1.5
1.3
—
—
—
0
0
401
4199
0.79
1.34
4.6
4.6
1.38
1.26
mmol/l
2.03
355
3790
9
43
2.11
1.31
1.8
2.0
—
—
—
0
0
6
24
2.52
1.30
2.3
1.3
—
—
—
0
0
417
4343
0.79
1.29
6.9
6.4
2.06
1.96
mu/l
0.68
387
4007
10
48
2.10
1.28
1.0
1.4
—
—
—
0
0
10
48
2.10
1.28
1.0
1.4
—
—
—
0
0
14
77
1.84
1.26
1.4
1.3
—
—
—
0
0
23
148
1.58
1.22
1.3
1.9
3.97
42.09
iu/l
—
6
61
15
86
1.77
1.20
1.7
1.4
—
—
—
0
0
15
86
1.77
1.20
1.7
1.4
—
—
—
0
0
185
1641
1.20
1.17
2.8
2.2
199.73
170.19
u/l
0.31
173
1550
8
39
2.07
1.15
1.0
1.1
—
—
—
0
0
24
159
1.53
1.14
2.5
1.9
—
—
—
0
0
7
30
2.35
1.12
1.4
1.0
—
—
—
0
0
7
30
2.35
1.12
1.4
1.0
—
—
—
0
0
7
30
2.35
1.12
1.4
1.0
—
—
—
0
0
429
4440
0.79
1.12
5.9
5.7
6.08
5.94
mmol/l
1.29
381
4036
5
21
2.39
1.09
1.6
1.1
—
—
—
0
0
117
1003
1.22
1.05
1.9
1.7
1181.80
1219.82
nmol/l
0.15
86
742
474
4616
1.36
1.04
32.1
18.4
139.24
139.75
mmol/l
4.12
465
4511
177
1581
1.18
1.02
1.8
1.7
20.93
21.71
nmol/l
0.25
147
1317
474
4619
1.35
1.01
32.1
18.6
3.95
3.96
mmol/l
0.33
465
4505
16
248
0.63
1.00
1.1
1.1
—
—
—
0
0
13
76
1.73
0.99
1.4
1.4
—
—
—
0
0
5
23
2.19
0.98
1.0
1.2
—
—
—
0
0
5
23
2.19
0.98
8.8
1.5
7.30
3.27
nmol/l
—
5
23
24
166
1.47
0.96
2.6
1.9
—
—
—
0
0
15
93
1.63
0.94
3.9
2.4
25.63
51.50
ug/min
—
8
58
86
1009
0.82
0.90
1.4
1.3
32.23
40.36
iu/ml
0.23
26
327
372
3880
0.85
0.89
5.8
5.0
15.35
15.01
pmol/l
1.71
344
3550
129
1135
1.18
0.88
1.8
1.8
410.18
14725742.51
pmol/l
0.80
104
910
11
64
1.73
0.86
1.3
1.1
—
73.20
—
0
10
82
962
0.82
0.86
1.4
1.3
9.18
12.99
u/ml
0.20
32
350
23
163
1.43
0.83
1.7
1.3
9.06
2.86
u/ml
—
5
22
23
163
1.43
0.83
1.7
1.3
7.79
3.93
u/ml
—
8
38
28
206
1.38
0.83
1.8
1.3
0.33
0.90
u/ml
—
6
12
16
105
1.54
0.82
5.4
3.9
18.28
26.13
mg/l
0.56
11
70
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
0
26
0.00
0.78
0.0
1.5
—
0.93
—
0
20
0
26
0.00
0.78
0.0
1.5
—
1.15
—
0
20
0
26
0.00
0.78
0.0
1.5
—
1.05
—
0
20
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
5
24
2.09
0.74
1.4
1.5
68.00
73.46
umol/l
—
5
24
18
125
1.46
0.73
1.6
1.2
1044.22
467.67
mg/l
0.70
18
119
7
39
1.81
0.72
1.3
1.1
—
—
—
0
0
16
229
0.69
0.72
1.3
1.3
—
—
—
0
0
5
26
1.93
0.71
1.0
1.0
—
—
—
0
0
5
27
1.86
0.68
1.2
1.0
—
—
—
0
0
5
92
0.54
0.67
1.2
1.2
0.88
0.91
g/l
—
5
92
5
29
1.73
0.64
1.2
1.1
—
98.75
—
0
8
23
175
1.33
0.59
1.3
1.5
—
—
—
0
0
252
2383
1.11
0.57
2.7
2.6
—
—
—
0
0
134
1223
1.13
0.57
6.3
4.6
1.02
1.02
kg/l
1.05
102
798
9
63
1.44
0.52
1.2
1.3
—
—
—
0
0
12
83
1.46
0.52
1.7
1.3
—
—
—
0
0
57
654
0.86
0.50
1.6
1.5
—
—
—
0
0
256
2439
1.10
0.48
2.7
2.6
77.77
81.65
nmol/l
1.14
217
2156
23
183
1.27
0.45
2.3
1.5
10.97
10.40
g/l
0.11
18
157
7
50
1.41
0.45
1.1
1.0
—
2.42
—
0
6
5
33
1.52
0.41
1.0
1.4
—
—
—
0
0
24
195
1.24
0.41
2.0
2.3
41.74
40.30
u/l
0.11
19
169
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.48
0.40
2.0
1.3
782.20
750.35
mg
—
5
34
25
205
1.23
0.40
2.5
1.5
3.37
3.73
g/l
0.92
20
180
25
205
1.23
0.40
2.5
1.5
4.29
4.37
g/l
0.20
20
180
25
205
1.23
0.40
2.5
1.5
7.24
7.74
g/l
1.18
20
180
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
12.31
—
0
9
19
152
1.26
0.37
1.5
1.4
268.00
304.73
ug/g
—
10
86
18
143
1.27
0.37
1.6
1.4
—
—
—
0
0
23
189
1.23
0.36
2.6
1.5
3.12
2.97
g/l
0.19
18
164
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
476
4710
1.15
0.31
35.5
20.0
74.62
72.06
umol/l
1.00
467
4642
21
176
1.20
0.29
1.3
1.2
—
—
—
0
0
18
149
1.22
0.28
1.2
1.3
—
—
—
0
0
186
1783
1.07
0.28
3.5
3.2
5.94
6.12
mmol/l
0.25
158
1478
8
64
1.25
0.27
1.8
1.5
472.00
300.66
mu/l
—
8
53
140
1330
1.07
0.27
5.4
3.9
0.00
0.00
estimate
0.50
59
400
15
123
1.23
0.25
1.1
1.6
—
—
—
0
0
36
322
1.13
0.24
1.6
1.5
1.62
1.39
%
1.19
28
276
104
983
1.07
0.23
3.5
4.6
62.59
288.40
ng/l
1.94
83
802
27
237
1.15
0.23
4.0
1.8
19.48
7.13
iu/ml
1.32
12
57
0
11
0.00
0.21
0.0
1.0
—
0.14
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
5
43
1.16
0.21
1.6
1.7
2.74
89.33
u/ml
—
5
43
6
50
1.20
0.19
3.5
3.4
—
—
—
0
0
6
51
1.18
0.19
1.0
1.2
—
—
—
0
0
468
4643
1.09
0.19
17.5
10.9
24.14
22.45
u/l
0.93
457
4466
17
195
0.87
0.18
1.4
1.7
—
—
—
0
0
5
69
0.72
0.17
2.0
5.0
223.40
350.36
umol/l
—
5
59
8
68
1.18
0.16
1.0
1.1
—
28.39
—
0
15
13
151
0.86
0.16
1.3
1.1
—
—
—
0
0
13
151
0.86
0.16
1.3
1.1
—
—
—
0
0
11
94
1.17
0.13
1.0
1.2
—
—
—
0
0
182
1779
1.04
0.12
4.6
3.9
10.31
6.47
mg/mmol
0.45
118
1011
116
1125
1.04
0.12
3.4
2.2
345.13
329.28
umol/l
0.64
99
961
11
96
1.15
0.10
1.1
1.6
—
—
—
0
0
5
48
1.04
0.09
6.6
2.7
12.00
11.87
index
—
5
15
7
66
1.06
0.08
1.6
1.2
81.53
18.31
u/l
—
7
58
15
137
1.10
0.07
2.2
1.7
2938.90
13987.31
e6/l
—
10
93
10
112
0.89
0.07
1.0
1.1
—
5.65
—
0
10
114
1117
1.03
0.07
1.3
1.3
0.80
1.66
u/ml
1.10
27
299
36
345
1.05
0.06
1.1
1.2
177.59
120.04
u/ml
0.44
11
145
23
219
1.05
0.04
1.6
1.8
—
—
—
0
0
61
624
0.97
0.04
5.0
5.5
34.97
34.04
%
0.33
34
393
355
3564
0.99
0.03
5.7
4.9
16.83
13.58
mm/h
3.32
324
3318
11
118
0.93
0.03
1.2
1.4
—
—
—
0
0
220
2189
1.01
0.02
3.4
3.0
147.71
90.56
ug/l
3.33
197
2012
40
393
1.02
0.01
1.5
1.5
—
—
—
0
0
240
2393
1.01
0.00
2.2
2.2
95.84
99.59
pmol/l
0.50
134
1109
476
4755
1.01
0.00
41.0
23.1
91.48
91.33
fl
0.30
468
4688
476
4756
1.01
0.00
41.1
23.1
260.54
258.38
e9/l
0.28
465
4633
476
4756
1.01
0.00
41.9
23.4
38.33
39.29
%
3.96
468
4689
476
4756
1.01
0.00
41.1
23.1
4.27
4.36
e12/l
4.09
463
4611
476
4757
1.01
0.00
41.6
23.3
126.91
130.99
g/l
8.64
469
4691
5
50
1.00
0.00
1.2
1.1
—
—
—
0
0
6
65
0.92
-0.00
1.0
1.2
—
—
—
0
0
6
63
0.95
-0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
15
150
1.00
-0.00
1.4
1.7
—
—
—
0
0
6
63
0.95
-0.00
1.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.1
—
0.63
—
0
8
5
49
1.02
-0.00
1.2
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
27.71
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
14.53
—
0
6
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
68
0.88
-0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
68
0.88
-0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
68
0.88
-0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_VULVA_WIDE – Malignant neoplasm of vulva, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).